All articles by Srivani Venna

  1. ExThera receives CE Mark approval for Seraph 100

    ExThera Medical has received CE Mark approval for its Seraph 100 Microbind Affinity Blood Filter (Seraph 100) to reduce pathogens…
    Read More…

    7 Aug
  2. Thai researchers develop new blood test for prostate cancer

    A research team at Mahidol University in Thailand has developed a blood test that can detect clinically significant prostate cancer…
    Read More…

    6 Aug
  3. RenalSense secures CE Mark approval for Clarity RMS technology

    RenalSense has obtained CE Mark approval for its Clarity RMS critical care system for real-time monitoring of urine flow in…
    Read More…

    6 Aug
  4. CSI acquires Wirion Embolic System from Gardia Medical

    Medical device company Cardiovascular Systems (CSI) has acquired the Wirion Embolic Protection System and related assets from Allium Medical Solutions’…
    Read More…

    6 Aug
  5. Sysmex wins manufacturing approval for RAS gene mutation testing

    Sysmex has secured the first manufacturing and marketing approval in Japan for the OncoBEAM RAS CRC Kit, which is used…
    Read More…

    5 Aug
  6. Medicrea wins FDA approval for TULIP GENESIS solution

    The Medicrea Group has secured approval from the US FDA for its top-loading screw solution TULIP GENESIS, completing its UNiD…
    Read More…

    5 Aug
  7. Scientists discover autoimmune disease linked to testicular cancer

    Scientists at Chan Zuckerberg (CZ) Biohub, Mayo Clinic and UC San Francisco have discovered an autoimmune disease that reportedly affects…
    Read More…

    8 Jul
  8. McMaster researchers identify new biomarkers for IBS diagnosis

    McMaster University researchers have identified new biomarkers for irritable bowel syndrome (IBS) in urine, which is expected to improve treatment…
    Read More…

    8 Jul
  9. Oncimmune signs agreement to commercialise EarlyCDT Lung test

    Oncimmune has signed an agreement with lung cancer diagnostic solutions company Biodesix to unlock the full potential of the EarlyCDT…
    Read More…

    1 Jul
  10. Thermo Fisher completes sale of Anatomical Pathology unit for $1.14bn

    Thermo Fisher Scientific has completed the sale of its Anatomical Pathology business to Japanese company PHC Holdings (PHCHD) in a…
    Read More…

    1 Jul
Close
Close
Close

Go Top